Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation

NCT00856505 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Diseases

Interventions

DRUG: Everolimus and mycophenolate sodium

Sponsor

University Hospital Freiburg